FDA approves decade-old Pfizer drug for rare childhood leukemia
A Pfizer leukemia drug that has been approved in adults for more than a decade will soon be available for kids 1 year and older.
Bosulif, also known as bosutinib, was approved by the FDA on Tuesday for children with a rare type of bone marrow cancer called chronic phase (CP) Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia (CML). Most patients with CML have an abnormal chromosome in their blood cells called the Philadelphia chromosome, named after its discovery by researchers in the Pennsylvania city.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.